Question 1

What is the share price of INFLUX HEALTHTECH LIMITED today?

Accepted Answer

INFLUX HEALTHTECH LIMITED (INFLUX) is trading at ₹257. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is INFLUX’s P/E ratio versus the sector?

Accepted Answer

INFLUX trades at a P/E of 31.8. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is INFLUX’s dividend yield?

Accepted Answer

INFLUX has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is INFLUX’s 52-week high and low?

Accepted Answer

INFLUX has traded between ₹256 and ₹264.9 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of INFLUX HEALTHTECH LIMITED?

Accepted Answer

INFLUX HEALTHTECH LIMITED has a market capitalisation of ₹608 crore.

Question 6

What is INFLUX’s return on equity?

Accepted Answer

INFLUX reports a return on equity of 27.9%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in —.

Question 7

Who are INFLUX’s competitors?

Accepted Answer

The Peers block on this page lists other — companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is INFLUX’s promoter holding?

Accepted Answer

Promoters hold 73.53% of INFLUX. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include INFLUX?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight INFLUX carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is INFLUX HEALTHTECH LIMITED a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from INFLUX’s own numbers. The judgement is yours.

Revenue	₹147 crore
Net profit	₹21 crore
Operating margin	20%
EPS	₹8.87

INFLUX

INFLUX

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

INFLUX financial summary